Desmethyl-VS-5584

CAS No. 1246535-95-4

Desmethyl-VS-5584( Desmethyl-VS-5584 | Desmethyl-VS5584 )

Catalog No. M17217 CAS No. 1246535-95-4

Desmethyl-VS-5584 is a dimethyl analog of VS-5584, which is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 86 In Stock
5MG 138 In Stock
10MG 243 In Stock
25MG 408 In Stock
50MG 601 In Stock
100MG 854 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Desmethyl-VS-5584
  • Note
    Research use only, not for human use.
  • Brief Description
    Desmethyl-VS-5584 is a dimethyl analog of VS-5584, which is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
  • Description
    Desmethyl-VS-5584 is a demethyl analogue of VS-5584, which is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Desmethyl-VS-5584 | Desmethyl-VS5584
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    mTOR| PI3K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1246535-95-4
  • Formula Weight
    340.39
  • Molecular Formula
    C16H20N8O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Nc1ncc(c2c3ncn(C(C)C)c3nc(N3CCOCC3)n2)cn1
  • Chemical Name
    5-[9-(1-Methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-2-pyrimidinamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shao Z,et al. VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo. PLoS One. 2015 Jul 23;10(7).
molnova catalog
related products
  • UNC2025 2HCl

    UNC2025 is a potent and orally bioavailable Mer/Flt3 dual inhibitor with IC50 of 0.8/0.74 nM for Mer/Flt3.

  • AZD-9574

    AZD-9574 is a selective inhibitor of PARP1 at the sites of SSBs. AZD-9574 exhibits anti-cancer activities and can be used in studies about HRD+ breast cancer and advanced solid malignancies.

  • PARP10-IN-3

    PARP10-IN-3 is a potent and selective mono-Adp-ribotransferase PARP10 inhibitor that inhibits human PARP10 (IC50:480 nM). PARP10-IN-3 also inhibited human PARP2 and human PARP15 with IC50 values of 1.7 μM.